Clinical Study
Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection
Table 2
Length of follow-up and of hospitalisation episodes.
| Variable | | Mean | Standard deviation | Min | Max |
| Follow-up prior to initiation of RLAI (years) | 177 | 2.00 | — | — | — | Follow-up following initiation of RLAI (years) | 177 | 1.80 | 0.45 | 0.43 | 2.56 | Proportion of patients hospitalised at initiation of RLAI | 177 | 127 (72%) | — | — | — | Hospital length of stay (days per episode) | | | | | | All Episodes | 576 | 65.0 | 95.4 | 0* | 816 | Episodes strictly before RLAI initiation | 227 | 45.6 | 53.2 | 1 | 405 | Episodes overlapping RLAI initiation | 128 | 120.1 | 145.0 | 9 | 816 | Episodes strictly after RLAI initiation | 221 | 53.0 | 80.3 | 0* | 638 |
|
|
*Inpatient hospitalisation episodes that recorded discharge on the day of admissions were assigned a duration of zero days.
|